Current role
Biotechnology · Healthcare
CEO, Board Member
2015-01-01–present
Thomas J. Schuetz
Board Member
Compass Therapeutics, Inc. (CMPX)Equibles does not estimate personal net worth.
Get an email with a short summary when Compass Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CMPX alertsAbout Thomas J. Schuetz
Thomas J. Schuetz is recorded as CEO at Compass Therapeutics, Inc. (CMPX) since June 17, 2020 and Board Member at Compass Therapeutics, Inc. (CMPX) since January 1, 2015. The newest filing on record that lists Thomas J. Schuetz as Board Member at Compass Therapeutics, Inc. (CMPX) is dated April 29, 2026. The proxy statement of Compass Therapeutics, Inc. reports total compensation of $5,097,150 for Thomas J. Schuetz in fiscal 2025, including a base salary of $630,000. Disclosed compensation is on record for 7 fiscal years. Compass Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Compass Therapeutics, Inc. includes Thomas Schuetz (CEO and Board Member), Thomas Schuetz, MD, PhD (CEO and Chairman), Vered Bisker-Leib, PhD (CEO and Board Member) and 7 others.
Affiliation history
-
Current
2020-06-17–present
-
Current
2015-01-01–present
Last confirmed April 29, 2026
Company network
Leadership on record at Compass Therapeutics, Inc.
- Thomas Schuetz CEO, Board Member
- Thomas Schuetz, MD, PhD CEO, Chairman
- Vered Bisker-Leib, PhD CEO, Board Member
- Barry Shin CFO
- Dr. Bisker-Leib COO
- Vered Bisker-Leib COO
- Jonathan E. Anderman General Counsel
- Neil Lerner Chief Accounting Officer
- Brett Kaplan, M.D. Board Member
- David Wurzer Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Compass Therapeutics, Inc. (CMPX) | MD., Ph.D. Chief Executive Officer | $630,000 | $5,097,150 |
| 2024 | Compass Therapeutics, Inc. (CMPX) | M.D., Ph.D. Chief Executive Officer | $575,000 | $3,093,057 |
| 2023 | Compass Therapeutics, Inc. (CMPX) | M.D., Ph.D. Chief Executive Officer | $575,000 | $4,873,206 |
| 2022 | Compass Therapeutics, Inc. (CMPX) | M.D., Ph.D. President of Research & Development (formerly CEO) | $550,000 | $2,115,185 |
| 2021 | Compass Therapeutics, Inc. (CMPX) | M.D., Ph.D. Chief Executive Officer | $4,000 | $5,258,000 |
| 2020 | Compass Therapeutics, Inc. (CMPX) | M.D., Ph.D. Chief Executive Officer | $4,000 | $2,556,793 |
| 2019 | Compass Therapeutics, Inc. (CMPX) | M.D., Ph.D. Chief Executive Officer | $400,000 | $1,373,843 |
Recent activity
No call appearances or filed executive changes recorded yet.